| Prev Close | 94.87 |
| Open | 94.68 |
| Day Low/High | 93.53 / 96.00 |
| 52 Wk Low/High | 89.65 / 159.54 |
| Volume | 453.70K |
Exact Sciences Corporation (EXAS)
94.25
0.62
0.65
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 171.95B |
| Market Cap | 16.11B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Jim Cramer: Let Me Explain How Good Companies Can Have Bad Stocks
Here's a lesson I learned decades ago at Goldman Sachs about how stocks can move in times like this.
Exact Sciences Has 2 Strategies - Bullish Fundamentals but Bearish Charts
The charts suggest further weakness is possible.
Investing Isn't an 'Exact Science' but the Charts Do Look Good
Investors can stay long EXAS, as it shows us bullish long-term potential.
Jim Cramer: Bank With Advanced Micro's Lisa Su and Go Along for the Ride
If you don't know Lisa Su by now I am tempted to say don't embarrass yourself, she may be the foremost executive of our time.
Exact Sciences Stock Could Sprint Higher in the Weeks Ahead
EXAS is likely to consolidate its recent gains.
Exact Sciences: Finding the Exact Price to Buy the Stock
Let's check the charts and indicators to see if this a good time and location to go long EXAS.
Exact Sciences Is Poised to Test New Highs on the Charts
Here's how to trade the stock right now.
Exact Sciences Looks Vulnerable: Protect Longs
Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.
Exact Sciences Stock: Buy at What Level?
Our strategy on EXAS shares after the company's latest earnings.
Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer
ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.
EXACT Sciences: Wait For a Better Buying Opportunity
The stock still looks vulnerable to further declines from a technical perspective.
Lackluster Market on Tons of Earnings
Some good discussions today on the Daily Diary. Look forward to continuing the conversation tomorrow as we look to wrap up a solid week for equities. Market was lackluster today but had a ton of earnings reports to take into account. Not to mention ...
Nasdaq Separates Itself From the Rest of the Market
Narrowing strength becomes a concern.
Major Indices' Support Holds, But Momentum Eases
Biotech shares have gained from takeovers in that sector.
Bullish and Bearish Reversals for the Week
Here's a window into what institutional investors may be doing and how to profit from that.
9-Day Churn Favors Upside Resolution
Tomorrow's FOMC decision is a convenient catalyst for a move.
Are Drug Stocks What's Ailing the Market?
This move in health care takes your breath away.
Canadian, Trina Solar Will Bounce Back Says Green Alpha Manager
Exact Sciences (EXAS) shares have pulled back in the past month due to a secondary offering and profit taking after a huge run-up.
Hard for Entry Points to Develop
A market like this is a negative for active traders.
Earnings Will Dictate
But I have doubts how easily a straight-up recovery can be pulled off.
The Trader Daily
Areas of interest on the SPY for Friday are about 185 and 184.
